Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 21, Issue SUPPL. 5, 2010, Pages

  Pentheroudakis, G ^a   Orecchia, R ^b   Hoekstra, H J ^c   Pavlidis, N ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPTERIN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BEVACIZUMAB; BUSULFAN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYTARABINE; FLUOROURACIL; GADOLINIUM; GEMCITABINE; IMATINIB; INTERFERON; METHOTREXATE; NAVELBINE; ONDANSETRON; OXALIPLATIN; PEMETREXED; RITUXIMAB; SORAFENIB; SUNITINIB; TAMOXIFEN; TECHNETIUM 99M; THIOTEPA; TRASTUZUMAB; TROPISETRON; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ACUTE LEUKEMIA; ADJUVANT THERAPY; ARTICLE; ASPIRATION BIOPSY; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CESAREAN SECTION; CHRONIC MYELOID LEUKEMIA; COLPOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CRYOPRESERVATION; ECHOGRAPHY; EUROPE; FEMALE FERTILITY; FOLLOW UP; HUMAN; INTRAUTERINE GROWTH RETARDATION; LYMPH NODE DISSECTION; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; MASTECTOMY; MEDICAL SOCIETY; MELANOMA; MUTAGENICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPANICOLAOU TEST; PATIENT CARE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY TERMINATION; PREMATURITY; PRIORITY JOURNAL; PUNCTURE; RADICAL HYSTERECTOMY; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SPONTANEOUS ABORTION; STILLBIRTH; TERATOGENICITY; THORAX RADIOGRAPHY; UTERINE CERVIX CANCER; VOMITING;

EID: 77954343477     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq198     Document Type: Article

References (47)

1. Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 2006; 42: 126-140.
2. Loibl S, Minckwitz G, Gwyn K et al. Breast carcinoma during pregnancy. International Recommendations from an Expert Meeting. Cancer 2006; 106: 237-246.
3. Mazze R, Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry of 5405 cases. Am J Obstet Gynecol 1989; 161: 1178-1185.
4. Mathelin C, Annane K, Treisser A et al. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res 2008; 28: 2447-2452.
5. Nicklas A, Baker M. Imaging strategies in pregnant cancer patients. Semin Oncol 2000; 27: 623-632.
6. International Commission on Radiological Protection. Biological Effects after Prenatal Irradiation (Embryo and Fetus). ICRP Publication 90. Ann ICRP 2003; 33: 5-206.
7. Cohen-Kerem R, Railton C, Oren D et al. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 2005; 190: 467-473.
8. Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg 2003; 138: 91-98.
9. Beadle BM, Woodward WA, Middleton LP et al. The impact of pregnancy on breast cancer outcomes in women >35 years. Cancer 2009; 115: 1174-1184.
10. Keleher AJ, Theriault RL, Gwyn KM et al. Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 2002; 194: 54-64.
11. Andrieu N, Goldgar DE, Easton DF et al. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 2006; 98: 535-544.
12. Spanheimer PM, Graham MM, Sugg SL et al. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol 2009; 16: 1143-1147.
13. Hacker NF, Berek JS, Lagasse LD et al. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 198; 59: 735-746.
14. Zemlickis D, Lishner M, Degendorfer P et al. Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol 199; 9: 1956-1961.
15. Reznek RH, Sahdev A. MR imaging in cervical cancer: seeing is believing. The 2004 Mackenzie Davidson Memorial Lecture. Br J Radiol 2005; 78 (Spec issue 2): S73-S85.
16. Alouini S, Rida K, Mathevet P. Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy. Gynecol Oncol 2008; 108: 472-477.
17. Muller CY, Smith HO. Cervical neoplasia complicating pregnancy. Obstet Gynecol Clin North Am 2005; 32: 533.
18. Ungar L, Smith JR, Palfalvi L et al. Abdominal radical trachelectomy during pregnancy to preserve pregnancy and fertility. Obstet Gynecol 2006; 108: 811-814.
19. van de Nieuwenhof HP, van Ham MA, Lotgering FK, Massuger LF. First case of vaginal radical trachelectomy in a pregnant patient. Int J Gynecol Cancer 2008; 18: 1381-1385.
20. Seamon LG, Downey GO, Harrison CR et al. Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy. Gynecol Oncol 2009; 114: 540-541.
21. Tewari K, Cappuccini F, Gambino A et al. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer 1998; 82: 1529-1534.
22. Daryanani D, Plukker JT, De Hullu JA et al. Pregnancy and early-stage melanoma. Cancer 2003; 97: 2248-2253.
23. Morton DL, Thompson JF, Cochran AJ et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317.
24. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283-291.
25. Mir O, Berveiller P, Ropert S et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008; 19: 607-613.
26. RobinsonAA,WatsonWJ,LeslieKK.Targetedtreatmentusingmonoclonalantibodies and tyrosine-kinase inhibitors in pregnancy. Lancet Oncol 2007; 8: 738-743.
27. Zambelli A, Prada GA, Fregoni V et al. Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy. Lung Cancer 2008; 60: 455-457.
28. Kal HB, Strukmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005; 6: 328-333.
29. International Commission on Radiological Protection. Pregnancy and Medical Radiation. Ann ICRP 2000: 30 iii-viii, 1-43.
30. Orecchia R, Lucignani G, Tosi G. Prenatal irradiation and pregnancy: the effcts of diagnostic imaging and radiation therapy. Recent Results Cancer Res 2008; 178: 3-20.
31. Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006; 107: 1120-1138.
32. Rodriguez AO, Chew H, Rosemary C et al. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008; 112: 71-78.
33. Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer 1991; 67: 869-872.
34. Kroman N, Jensen MB, Wohlfahrt J, Ejlertsen B. Pregnancy after treatment of breast cancer-a population-based study on behalf of DBCCG. Acta Oncologica 2008; DOI 10.1080/02841860801935491.
35. Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: a population based study. BMJ 2007; 334: 194.
36. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006; 24: 5769-5779.
37. Borde F, Chapelle-Marcilac IFP, Hery M et al. Role of chemo-induced amenorrhea in premenopausal, node positive, operable breast cancer patients. Nine-year follow up results of FASG database. Breast Cancer Res Treat 2003; 82 (Suppl 1): 30.
38. Cuzick J. The impact of LHRH agonists on breast cancer recurrence and mortality: an overview of the randomized trials. Breast Cancer Res Treat 2006; 100 (Suppl 1): S10.
39. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001; 2: 173-177.
40. Lee SJ, Schover LR, Partridge AH et al. ASCO Recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917-2931.
41. Gerber B, Dieterich M, Muller H, Reimer T. Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Res Treat 2008; 108: 1-7.
42. Gerber B, Stehle H, Ricardo F et al. ZORO: A prospective randomized multicenter study to prevent chemotherapy-induced ovarian failure with the GnRH-agonist goserelin in young hormone-insensitive breast cancer patients receiving anthracycline containing (neo-) adjuvant chemotherapy (GBG 37). J Clin Oncol 2009; 27 (15 Suppl): Abstr 526.
43. Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 2009; 91: 694-697.
44. Shin D, Lo KC, Lipshultz LI. Treatment options for the infertile male with cancer. J Natl Cancer Inst Monogr 2005; 34: 48-50.
45. Orwig KE, Schlatt S. Cryopreservation and transplantation of spermatogonia and testicular tissue for preservation of male fertility. J Natl Cancer Inst Monogr 2005; 34: 51-56.
46. Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv 2006; 62: 58-72.
47. Donnez J, Martinez-Madrid B, Jadoul P et al. Ovarian tissue cryopreservation and transplantation: a review. Human Reprod Update 2006; 12: 519-535.